Teva Pharmaceutical Industries Ltd. (TEVA) and Procter & Gamble Co. (PG) agreed to combine their consumer-health businesses outside North America in a joint venture that aims to capture more of the $200 billion market for over-the-counter medicines.

The copy of the press release is found by Googling Procter and Gamble and Teva joint venture. I believe the following address will work http://news.pg.com/press-release/pg-corporate-announcements/procter-gamble-company-and-teva-pharmaceutical-industries-a (Links to an external site.)Links to an external site. (but do not guarantee this since the internet changes).

After reviewing this article, do you think this is a wealth increasing project for P&G? why or why not? And what competitive advantages does P&G bring to this joint venture? What capital projects/ investment will be needed?